CS/CS/HB 1617: Stem Cell Therapy
GENERAL BILL by Health & Human Services Committee ; Health Professions & Programs Subcommittee ; Buchanan ; (CO-INTRODUCERS) Black
Stem Cell Therapy ; Authorizes allopathic physicians & osteopathic physicians to perform stem cell therapy not approved by United States Food & Drug Administration; specifies requirements for stem cells that may be used by allopathic physicians & osteopathic physicians; requires allopathic physicians & osteopathic physicians to adhere to applicable current good manufacturing practices in performance of such therapies; prohibits allopathic physicians & osteopathic physicians from obtaining stem cells for therapies from facilities failing to meet certain requirements; requires allopathic physicians & osteopathic physicians to include certain terms in contracts or agreements with facilities producing stem cells for therapies; requires allopathic physicians & osteopathic physicians to include specified notice in any form of advertisement; provides requirements for such notice; requires allopathic physicians & osteopathic physicians to obtain signed consent form from patient or his or her representative before performing therapy; specifies requirements for consent form; requires Board of Medicine & Board of Osteopathic Medicine to adopt rules, respectively.
Last Action: 4/24/2025 House - Added to Second Reading Calendar
Bill Text: PDF
Bill History
| Date | Chamber | Action |
|---|---|---|
| 2/28/2025 | House |
• Filed |
| 3/4/2025 | House |
• 1st Reading (Original Filed Version) |
| 3/5/2025 | House |
• Referred to Health Professions & Programs Subcommittee • Referred to Health & Human Services Committee • Now in Health Professions & Programs Subcommittee |
| 4/1/2025 | House |
• Added to Health Professions & Programs Subcommittee agenda |
| 4/3/2025 | House |
• Favorable with CS by Health Professions & Programs Subcommittee • Reported out of Health Professions & Programs Subcommittee • Laid on Table under Rule 7.18(a) • CS Filed • 1st Reading (Committee Substitute 1) |
| 4/4/2025 | House |
• Referred to Health & Human Services Committee • Now in Health & Human Services Committee |
| 4/21/2025 | House |
• Added to Health & Human Services Committee agenda |
| 4/22/2025 | House |
• Favorable with CS by Health & Human Services Committee • Reported out of Health & Human Services Committee • Laid on Table under Rule 7.18(a) • CS Filed • 1st Reading (Committee Substitute 2) |
| 4/24/2025 | House |
• Bill referred to House Calendar • Added to Second Reading Calendar |
